These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

116 related articles for article (PubMed ID: 9398632)

  • 1. Detection of apolipoprotein E/dimeric soluble amyloid beta complexes in Alzheimer's disease brain supernatants.
    Permanne B; Perez C; Soto C; Frangione B; Wisniewski T
    Biochem Biophys Res Commun; 1997 Nov; 240(3):715-20. PubMed ID: 9398632
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Apolipoprotein E: binding to soluble Alzheimer's beta-amyloid.
    Wisniewski T; Golabek A; Matsubara E; Ghiso J; Frangione B
    Biochem Biophys Res Commun; 1993 Apr; 192(2):359-65. PubMed ID: 8484748
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Apolipoprotein E co-localizes with newly formed amyloid beta-protein (Abeta) deposits lacking immunoreactivity against N-terminal epitopes of Abeta in a genotype-dependent manner.
    Thal DR; Capetillo-Zarate E; Schultz C; Rüb U; Saido TC; Yamaguchi H; Haass C; Griffin WS; Del Tredici K; Braak H; Ghebremedhin E
    Acta Neuropathol; 2005 Nov; 110(5):459-71. PubMed ID: 16195918
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Apolipoprotein E isoforms in Alzheimer's disease pathology and etiology.
    Baum L; Chen L; Ng HK; Pang CP
    Microsc Res Tech; 2000 Aug; 50(4):278-81. PubMed ID: 10936880
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Astrocyte lipoproteins, effects of apoE on neuronal function, and role of apoE in amyloid-beta deposition in vivo.
    Fagan AM; Holtzman DM
    Microsc Res Tech; 2000 Aug; 50(4):297-304. PubMed ID: 10936884
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Differential effects of apolipoprotein E isoforms on metal-induced aggregation of A beta using physiological concentrations.
    Moir RD; Atwood CS; Romano DM; Laurans MH; Huang X; Bush AI; Smith JD; Tanzi RE
    Biochemistry; 1999 Apr; 38(14):4595-603. PubMed ID: 10194381
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Brain uptake of circulating apolipoproteins J and E complexed to Alzheimer's amyloid beta.
    Zlokovic BV; Martel CL; Mackic JB; Matsubara E; Wisniewski T; McComb JG; Frangione B; Ghiso J
    Biochem Biophys Res Commun; 1994 Dec; 205(2):1431-7. PubMed ID: 7802679
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Gene delivery of human apolipoprotein E alters brain Abeta burden in a mouse model of Alzheimer's disease.
    Dodart JC; Marr RA; Koistinaho M; Gregersen BM; Malkani S; Verma IM; Paul SM
    Proc Natl Acad Sci U S A; 2005 Jan; 102(4):1211-6. PubMed ID: 15657137
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Isoform-specific interactions of human apolipoprotein E to an intermediate conformation of human Alzheimer amyloid-beta peptide.
    Stratman NC; Castle CK; Taylor BM; Epps DE; Melchior GW; Carter DB
    Chem Phys Lipids; 2005 Oct; 137(1-2):52-61. PubMed ID: 16140289
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Seeding of A beta fibril formation is inhibited by all three isotypes of apolipoprotein E.
    Wood SJ; Chan W; Wetzel R
    Biochemistry; 1996 Sep; 35(38):12623-8. PubMed ID: 8823200
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Apolipoprotein E facilitates neuritic and cerebrovascular plaque formation in an Alzheimer's disease model.
    Holtzman DM; Fagan AM; Mackey B; Tenkova T; Sartorius L; Paul SM; Bales K; Ashe KH; Irizarry MC; Hyman BT
    Ann Neurol; 2000 Jun; 47(6):739-47. PubMed ID: 10852539
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Greasing the wheels of Abeta clearance in Alzheimer's disease: the role of lipids and apolipoprotein E.
    Fan J; Donkin J; Wellington C
    Biofactors; 2009; 35(3):239-48. PubMed ID: 19472365
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Cerebrospinal fluid beta-amyloid1-42 and tau in control subjects at risk for Alzheimer's disease: the effect of APOE epsilon4 allele.
    Sunderland T; Mirza N; Putnam KT; Linker G; Bhupali D; Durham R; Soares H; Kimmel L; Friedman D; Bergeson J; Csako G; Levy JA; Bartko JJ; Cohen RM
    Biol Psychiatry; 2004 Nov; 56(9):670-6. PubMed ID: 15522251
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Independent effects of APOE on cholesterol metabolism and brain Abeta levels in an Alzheimer disease mouse model.
    Mann KM; Thorngate FE; Katoh-Fukui Y; Hamanaka H; Williams DL; Fujita S; Lamb BT
    Hum Mol Genet; 2004 Sep; 13(17):1959-68. PubMed ID: 15229191
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Apolipoprotein E, amyloid-beta, and blood-brain barrier permeability in Alzheimer disease.
    Donahue JE; Johanson CE
    J Neuropathol Exp Neurol; 2008 Apr; 67(4):261-70. PubMed ID: 18379441
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Aging, gender and APOE isotype modulate metabolism of Alzheimer's Abeta peptides and F-isoprostanes in the absence of detectable amyloid deposits.
    Yao J; Petanceska SS; Montine TJ; Holtzman DM; Schmidt SD; Parker CA; Callahan MJ; Lipinski WJ; Bisgaier CL; Turner BA; Nixon RA; Martins RN; Ouimet C; Smith JD; Davies P; Laska E; Ehrlich ME; Walker LC; Mathews PM; Gandy S
    J Neurochem; 2004 Aug; 90(4):1011-8. PubMed ID: 15287908
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Higher avidity binding of apolipoprotein (E-AII) complex than of apolipoprotein E monomer to beta-amyloid.
    Yamauchi K; Tozuka M; Nakabayashi T; Sugano M; Hidaka H; Kondo Y; Katsuyama T
    J Neurosci Res; 1999 Oct; 58(2):301-7. PubMed ID: 10502286
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Amyloid-associated proteins alpha 1-antichymotrypsin and apolipoprotein E promote assembly of Alzheimer beta-protein into filaments.
    Ma J; Yee A; Brewer HB; Das S; Potter H
    Nature; 1994 Nov; 372(6501):92-4. PubMed ID: 7969426
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Biology of A beta amyloid in Alzheimer's disease.
    Wisniewski T; Ghiso J; Frangione B
    Neurobiol Dis; 1997; 4(5):313-28. PubMed ID: 9440120
    [TBL] [Abstract][Full Text] [Related]  

  • 20. An apolipoprotein E-based therapeutic improves outcome and reduces Alzheimer's disease pathology following closed head injury: evidence of pharmacogenomic interaction.
    Wang H; Durham L; Dawson H; Song P; Warner DS; Sullivan PM; Vitek MP; Laskowitz DT
    Neuroscience; 2007 Feb; 144(4):1324-33. PubMed ID: 17187933
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 6.